Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALVR |
---|---|---|
09:32 ET | 123 | 0.79 |
09:48 ET | 132 | 0.7605 |
10:03 ET | 100 | 0.7897 |
10:10 ET | 400 | 0.7897 |
10:12 ET | 100 | 0.771 |
10:21 ET | 721 | 0.771 |
10:24 ET | 2935 | 0.7813 |
10:26 ET | 20624 | 0.7878 |
10:28 ET | 200 | 0.7789 |
10:30 ET | 125 | 0.7878 |
10:33 ET | 300 | 0.7878 |
10:35 ET | 100 | 0.7879 |
10:42 ET | 1500 | 0.7735 |
10:48 ET | 750 | 0.7807 |
10:50 ET | 100 | 0.7879 |
10:57 ET | 855 | 0.78325 |
11:00 ET | 5000 | 0.789799 |
11:02 ET | 31089 | 0.79 |
11:04 ET | 32959 | 0.79 |
11:06 ET | 2812 | 0.7908 |
11:08 ET | 100 | 0.7908 |
11:09 ET | 1776 | 0.7908 |
11:13 ET | 8800 | 0.7908 |
11:15 ET | 600 | 0.8 |
11:18 ET | 530 | 0.7908 |
11:20 ET | 550 | 0.7908 |
11:22 ET | 150 | 0.7817 |
11:24 ET | 6559 | 0.7908 |
11:29 ET | 200 | 0.79075 |
11:31 ET | 700 | 0.79075 |
11:40 ET | 200 | 0.799 |
11:42 ET | 602 | 0.7998 |
11:45 ET | 200 | 0.7908 |
11:47 ET | 600 | 0.79075 |
11:49 ET | 902 | 0.79 |
11:51 ET | 100 | 0.78585 |
11:54 ET | 100 | 0.79 |
11:58 ET | 300 | 0.79 |
12:00 ET | 9200 | 0.7817 |
12:03 ET | 432 | 0.7859 |
12:05 ET | 100 | 0.7859 |
12:07 ET | 300 | 0.79 |
12:09 ET | 100 | 0.79 |
12:14 ET | 100 | 0.7899 |
12:16 ET | 300 | 0.7899 |
12:18 ET | 238 | 0.7899 |
12:21 ET | 450 | 0.7899 |
12:23 ET | 100 | 0.7819 |
12:25 ET | 2200 | 0.79 |
12:34 ET | 300 | 0.7862 |
12:39 ET | 200 | 0.7903 |
12:41 ET | 300 | 0.7904 |
12:48 ET | 399 | 0.79 |
12:50 ET | 100 | 0.7862 |
12:54 ET | 300 | 0.7903 |
12:57 ET | 100 | 0.7903 |
01:01 ET | 400 | 0.7903 |
01:03 ET | 300 | 0.7903 |
01:14 ET | 100 | 0.78625 |
01:15 ET | 1038 | 0.7903 |
01:17 ET | 100 | 0.7902 |
01:19 ET | 1420 | 0.7903 |
01:24 ET | 100 | 0.7831 |
01:26 ET | 200 | 0.7903 |
01:33 ET | 703 | 0.79 |
01:35 ET | 100 | 0.7904 |
01:37 ET | 100 | 0.7905 |
01:39 ET | 100 | 0.7887 |
01:42 ET | 300 | 0.7905 |
01:50 ET | 1563 | 0.7934 |
01:51 ET | 147 | 0.7933 |
01:57 ET | 300 | 0.7997 |
02:00 ET | 200 | 0.7933 |
02:06 ET | 100 | 0.7997 |
02:09 ET | 100 | 0.7933 |
02:15 ET | 563 | 0.7933 |
02:20 ET | 301 | 0.7933 |
02:24 ET | 300 | 0.7997 |
02:29 ET | 100 | 0.7933 |
02:33 ET | 100 | 0.7996 |
02:36 ET | 400 | 0.7997 |
02:38 ET | 289 | 0.787 |
02:40 ET | 200 | 0.7948 |
02:42 ET | 200 | 0.7933 |
02:44 ET | 100 | 0.7933 |
02:47 ET | 1089 | 0.7996 |
02:54 ET | 200 | 0.7996 |
02:56 ET | 18500 | 0.79 |
03:00 ET | 302 | 0.7868 |
03:03 ET | 1000 | 0.7868 |
03:05 ET | 5802 | 0.783 |
03:09 ET | 5000 | 0.7903 |
03:16 ET | 5300 | 0.78685 |
03:18 ET | 100 | 0.7913 |
03:21 ET | 5356 | 0.7902 |
03:25 ET | 600 | 0.7869 |
03:27 ET | 200 | 0.7869 |
03:30 ET | 100 | 0.7915 |
03:32 ET | 348 | 0.7916 |
03:36 ET | 552 | 0.7822 |
03:43 ET | 1630 | 0.7841 |
03:48 ET | 22718 | 0.7916 |
03:50 ET | 21143 | 0.786 |
03:52 ET | 800 | 0.7899 |
03:57 ET | 8067 | 0.7948 |
03:59 ET | 6136 | 0.799 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Allovir Inc | 86.5M | -0.7x | --- |
Bioatla Inc | 87.5M | -0.7x | --- |
Sellas Life Sciences Group Inc | 84.9M | -1.3x | --- |
Genelux Corp | 84.3M | -2.2x | --- |
Hillevax Inc | 91.1M | -0.5x | --- |
Ovid Therapeutics Inc | 84.5M | -2.8x | --- |
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $86.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 115.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-1.23 |
Book Value | $1.28 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.